ABBV vs GOOG: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Alphabet Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Alphabet Inc. · Communication Services
$334.98
+15.8% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
GOOG has more upside to fair value
(+15.8%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
GOOG |
| Current Price |
$261.70 |
$334.98 |
| Fair Value Estimate |
$259.04 |
$387.82 |
| Upside to Fair Value |
-1.0%
|
+15.8%
|
| Market Cap |
$462.4B |
$4,065.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
12.7x
|
| Price / Sales |
7.2x
|
9.1x
|
| Price / FCF |
23.6x
|
76.4x
|
| Revenue Growth YoY |
+10.2%
|
+24.2%
|
| Gross Margin |
71.5%
|
60.9%
|
| Operating Margin |
29.3%
|
33.1%
|
| Return on Equity |
-136.5%
|
50.8%
|
| Dividend Yield |
2.61% |
0.26% |
| FCF Yield |
4.25%
|
1.31%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Alphabet Inc. is the parent of Google Services, Google Cloud, and Other Bets, monetizing Search, YouTube, Android, Chrome, Google Play, Workspace, and enterprise cloud and AI infrastructure across the globe with roughly 190,820 full-time employees. The business quality is high: trailing-twelve-month gross margin is 60.9%, operating margin is 33.1%, net margin is 54.8%, and return on equity is 50.…
Accumulation Zones
| Metric |
ABBV |
GOOG |
| Zone Low |
$194.28 |
$290.87 |
| Zone High |
$220.18 |
$329.65 |
| In Buy Zone? |
No
|
No
|